InSCREENeX GmbH is a spin-off of the Helmholtz Centre for Infection Research.
The founder is Dr. rer. nat. Roland Schucht. InSCREENeX GmbH is located in state-of-the-art laboratory and office facilities within the Helmholtz Centre for Infection Research, Braunschweig, Germany.
Using state of the art genetic manipulation techniques to engineer cells, InSCREENeX offers novel, user friendly, mam- malian cell systems as decision tools for drug development processes. These developed systems have the benefits of biological relevance and convenience.
The discovery of novel drugs is a challenging, costly, time con- suming and inefficient process. To address these problems, InSCREENeX offers innovative and unique SCREENflex™ and CI-SCREEN™ product solutions to expedite drug discovery and enable biologically relevant tests in vitro to provide complementary, cellular screening tools aimed at all stages of the drug development process.